hVIVO plc (LON:HVO - Get Free Report)'s stock price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 24.90 ($0.31) and traded as low as GBX 19 ($0.24). hVIVO shares last traded at GBX 19.50 ($0.24), with a volume of 606,288 shares trading hands.
hVIVO Stock Down 0.7 %
The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The company has a market cap of £133.05 million, a price-to-earnings ratio of 651.83 and a beta of 0.97. The stock's 50-day moving average is GBX 24.75 and its 200-day moving average is GBX 27.13.
About hVIVO
(
Get Free Report)
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
Before you consider hVIVO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and hVIVO wasn't on the list.
While hVIVO currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
